Abstract

1
Neural circuit-based guidance for optimizing patient screening, target selection and 2 parameter tuning for deep brain stimulation (DBS) remains limited. To this end, we 3 propose a functional brain connectome-based modeling approach that simulates 4 network-spreading effects of stimulating different brain regions and quantifies 5 rectification of abnormal network topology in silico. We validate these analyses by 6 predicting nuclei in basal-ganglia circuits as top-ranked targets for 43 local patients 7 with Parkinson's disease and 90 patients from public database. However, individual 8
connectome-based predictions demonstrate that globus pallidus and subthalamic 9 nucleus (STN) constituted as the best choice for 21.1% and 19.5% of patients, 10 respectively. Notably, the priority rank of STN significantly correlated with motor 11 symptom severity in the local cohort. By introducing whole-brain network diffusion 12 dynamics, these findings unfold a new dimension of brain connectomics and 13 underscore the importance of neural network modeling for personalized DBS therapy, 14 which warrants experimental investigation to validate its clinical utility. 15
Brain stimulation via optic, sonic, electrical and magnetic means enables the 1 adjustable and selectable modulation of network-level activity, thereby producing 2 varying degrees of therapeutic effects. As one of the most successful 3 neuromodulation-based clinical interventions, deep brain stimulation (DBS) has 4 demonstrated remarkable symptomatic amelioration in a wide range of neurological 1, 5 2, 3, 4, 5 , and psychiatric conditions 6, 7 . However, the clinical efficacy of brain 6 stimulation is unpredictable on a case-by-case basis, as it is inevitably susceptible to 7 unexpected postoperative side effects on cognitive function, mood and behavior 8, 9, 10 . 8
This may be partially caused by our incomplete understanding of its neural 9 circuit-level mechanisms 2, 4, 5, 11, 12 . Meanwhile, considerable variability in terms of 10 heterogeneous neuropathology, clinical trajectory and treatment protocols exists 11 between individual patients. To date, there are no theoretical principles or pre-surgical 12 consensuses for the determination of desirable stimulation targets (e.g. pallidal versus 13 subthalamic DBS) 13, 14, 15, 16, 17 and the fine-tuning of stimulation parameters (e.g., 14 current amplitude, frequency, and pulse-width etc.) 4, 9, 10 to optimize a single patient's 15 outcome. Inter-individual differences in stimulation-induced effects therefore pose a 16 tremendous challenge for pertinent empirical studies and therapeutic interventions 17 alike, heightening the urgent demand for optimizing patient-specific stimulation 18 protocols 15, 18 . 19
The functional brain connectome constructed from resting-state functional 20 connectivity is powerful in characterizing the nature of topological organization 19, 20, 21 21, 22, 23 and the neuropathology of the diseased brain 24, 25, 26, 27 . Grounded in network 1 science and graph theory, the human connectome can be readily formulated as a brain 2 graph or matrix consisting of nodes (parcellated brain regions) and edges (connections 3 between nodes) 20 . Emerging evidence suggests that both invasive and noninvasive 4 therapeutics can reconfigure brain networks and normalize maladaptive functional 5 connectivity of brain circuitry concomitantly with clinical symptomatic improvement 6 28, 29, 30 . In other words, the therapeutic effects of neurostimulation are attributable to 7 the rectification or rebalance of abnormal network topology associated with 8 pathological behaviors 11, 31, 32, 33 . This has enabled the development of a variety of 9 whole-brain computational models with an emphasis on clinical applications 18 . 17
However, no existing neural circuit-based methods can be harnessed to guide patient 18 screening or to predict treatment outcome before surgical intervention 2, 4, 31 . 19
To address these bedrock issues, we propose a functional connectome-based 20 neuromodeling approach by which we are able to predict neurostimulation targets and 21 97.7% of the local cohort, upholding striking agreement with prior clinical results 40 . 1 Intriguingly, we found a significant relationship between the rank of the STN in this 2 cohort and the severity of symptoms as indexed by UPDRS-III (p < 0.05, Kendall 3 rank correlation), but not for any other top sites. Moreover, we made personalized 4 predictions of optimal strengths for each region in individual patients of the local As a robust test of generalizability, we applied the present modeling analysis to a 13 completely independent validation dataset from the public PPMI database, which 14 provides resting-state fMRI data for 90 patients with PD ( Figure 5 ). We observed that 15 nuclei of the basal ganglia circuit and hippocampus stand out as the prioritized 16 selections, in agreement with results from the local PD cohort ( Figure 5A ). 17 Correspondingly, we found that optimal neurostimulation strengths for the GP, STN, 18 caudate, putamen and hippocampus are almost identical to those in the local group 19 (58%, 82%, 84%, 40% and 52% down-regulation shown in Figure 3B , respectively). 20
At the single subject level, the predicted top-five targets for each patient in the public 21 cohort are also consistent with those of the local group. Stimulation of regions 1 including the GP, STN, thalamus, putamen, hippocampus and amygdala demonstrates 2 significant percentage improvement (p<10 -20 , one sample t-test, left panel of Figure  3 5C) in this group with large effect sizes (Cohen's d > 1.3, right panel of Figure 5C ). 4
The GP and STN are the best targets for 17 (18.9%) and 15 (16.7%) patients, and 5 top-five choices for 77 (85.6%) and 67 (74.4%) patients, respectively ( Figure 5D ). 6
The caudate, thalamus, hippocampus and amygdala are the best choices for 45 7 (50.0%), 2 (2.2%), 8 (8.9%) and 1 (1.1%) individual patients, respectively, and 8 top-five choices for 66 (73.3%), 50 (55.6%), 75 (83.3%) and 24 (26.7) patients 9 (Figure5D). We can therefore summarize the nuclei of the basal ganglia circuits as 10 prioritized targets for 87.8% and as top-five choices for 100% of this public group. 11
Note that we did not observe a statistically significant relationship between the ranks 12 of any top-five sites and the severity of motor symptoms in the public cohort (p > 0.05, 13
Kendall rank correlation). Meanwhile, personalized predictions of optimal strength 14 for each region are shown for the public cohort in Figure 5E . Nevertheless, we observed a rather large proportion of patients (51.2% in local 20 cohort, 35.6% in public cohort) for whom the best target was neither the GP nor the 21 1 ganglia circuits ranked extremely low, suggesting that focal stimulation therapeutics 2 may not be appropriate for them at all. Hence, our computational approach provides a 3 more tailored strategy to guide individualized selection between these candidate 4 targets, thereby improving the overall outcome of neurostimulation 15 . It has been 5 shown that the thalamus was the best choice for stimulation in patients with severe 6 tremor-related symptoms 52 . The putamen, another key component of the basal 7 ganglia circuits, was identified among top-ranking candidates, which is consistent 8 with prior experience in patients 53 . Interestingly, the caudate emerged as a good 9 candidate for some patients, especially in the public cohort ( Figure 5 ), despite its 10 occurrence as a common target for stimulation in patients with epilepsy 47 or 11 psychiatric conditions 6 . Treatment outcomes for the caudate had high variation as 12 may lead to relatively small effect size. Surprisingly, the hippocampus was identified 13 here as a potential target, most likely because it emerged as one of key abnormal 14 nodes comparing the brain matrices of patients to controls. And it is known to be 15 pathologically involved in the non-motor clinical symptoms of Parkinsonism 54 . 16
However, it has not been reported hitherto in the clinical treatment of PD patients and 17 future investigation in animal and human subjects is required to test experimental 18 outcomes of stimulation in this area. 19
Neurostimulation strength is another critical parameter affecting therapeutic 20 outcomes in individuals. Determination of optimal strength in our modeling is 21 analogous to the programming of a DBS device in individual patients, which often 1 demands labor-intensive adjustment based on frequent symptom assessment by 2 clinicians. In the present study, the priority of all brain regions as potential 3 neurostimulation targets is ranked in each single patient when the optimal stimulation 4 strength is applied to each area. Our predictions clearly show that excessively strong 5 or weak neurostimulation may not result in desirable modulation even at an 6 appropriately selected target, and that optimal strengths (including up-or 7 down-regulation) vary substantially among different targets across patients. These 8 findings may serve as theoretical guidance for the tuning of stimulation protocols and 9 possibly obviate the need for testing by trial and error on human subjects. This is a 10 rather attractive premise, as brain stimulation with inappropriate parameters usually participants were instructed to lie still in the scanner with their eyes closed, remain 8 awake, and not think of anything in particular (adherence was confirmed by 9 participants immediately after the scan). 10
Anatomical and resting-state fMRI data from the public PPMI dataset were 11 acquired on Siemens Tim Trio 3.0 T scanners. Structural images were recorded using 12 a similar protocol as described above. Resting-state fMRI images were acquired for 13 210 volumes using an echo-planar imaging sequence (TR/TE = 2400/25 ms, flip angle 14 = 80°, in-plane resolution = 3.3×3.3 mm 2 , slice thickness = 3.3 mm, 40 axial slices). 15
Further technical details can be found in the MRI operation manual available at 16
18
Network construction 19
The fMRI data were minimally preprocessed using Statistical Parametric Mapping 20 (SPM, http://www.fil.ion.ucl.ac.uk/spm). The first 10 volumes were discarded for 21 signal equilibrium and the remaining volumes were corrected for temporal difference 1 in slice acquisition and rigid-body head movement. The corrected data were spatially 2 normalized to the MNI (Montreal Neurological Institute) space and resampled to 3 3 mm isotropic voxels. After normalization, six motion parameters (three for translation 4 and three for rotation) estimated during the realignment process were regressed out 5 and linear drift was removed. A band-pass filter (0.01 -0.08 Hz) was applied to 6 remove the low frequency drift and high frequency respiratory and cardiac noise. We 7 constructed the whole-brain connectivity network using a custom parcellation scheme 8 based on the standard Automated Anatomical Labeling (AAL) atlas with the addition 9 of the subthalamic nucleus as defined by the ATAG subcortical atlas 56 (the details of 10 a total of 92 brain regions are listed in Supplemental information Table S1 ). The time 11 series of all voxels within each region were extracted and averaged to obtain a mean 12 time series. Functional connectivity f ij between brain regions was represented by 13 calculating the Pearson correlation coefficients between the mean time series of any 14 pair of parcellated regions (i and j). A 92×92 connectivity matrix F was generated for 15 each subject and then subjected to Fisher's Z-transformation for subsequent analysis. 16 17
Whole-brain network model of neurostimulation 18
We first simulated the network effects of neurostimulation by considering the 19 constructed connectome F as the resultant network of information spread or diffusion 20 over a direct network D. The rationale here is that the local effect is the action of 21 stimulation imposed on the direct network D, and the globally distributed effect is the 1 propagation result of the local effect on the direct network. As such, we adopted a 2 network deconvolution algorithm 57 to derive a direct network D from the observed 3 network F, and used the corresponding transformation rule, transitive closure, to 4 simulate the global effects of local stimulation on a large-scale neuronal network. A 5 detailed description of the modeling is provided in the Supplemental Information. We 6 then denote a hypothetical neurostimulation event as a regulation operator P, which is 7 imposed onto the direct network D (i.e.,۲
, where ۨ is the element-wise 8 product of two matrices). If neurostimulation targets one pair of bilateral loci, most P 9 entries will have a value of one, with the exception of two columns and two rows that 10 are directly connected to the locus. For simplicity, the same value that represents the 11 neurostimulation strength is applied to the remaining entries in P: a value larger than 12 one signifies up-regulation, whereas a value smaller than one indicates 13 down-regulation (e.g., 1.5 represents a 50% up-regulation, 0.7 represents a 30% 14 down-regulation). Finally, the neurostimulation-tuned direct network Figure S6A and S6B. In 3 order to compare the outcomes across brain regions, individuals, and groups, we 4 standardized all outcome similarities using relative change, defined as follows: 5
Relative change was used as a quantitative measure to represent the percentage 6 improvement in connectomic similarity towards a healthy regime that is achieved by 7 neurostimulation. The higher the connectomic similarity with the matrix of the 8 healthy subject group, the better the simulated therapeutic effect is. At each targeted 9 brain region, the up-or down-regulation magnitude that resulted in the highest 10 relative change was deemed as the best strength. All target regions were then ranked 11 according to their relative change at optimal neurostimulation strength. Higher ranks 12 indicate desirable stimulation candidates with better therapeutic effects. All 13 predictions were made at both single patient and patient group levels, as illustrated in 14 Figure 1B . 15
16
Study design, statistical analysis and cross-validation 17
As a proof-of-principle study, we rigorously tested the robustness and consistency of 18 the predicted results using various cross-validation procedures. To validate whether 19 the model is biased by the inclusion or exclusion of subject data, we randomly 20 sampled half of the PD and HC groups 1000 times for predictions. Unblinding of 1 between-group labels is also necessary to generate cross-validated prediction 2 accuracies. We randomly sampled half of the HC group 1000 times as the "patient 3 group" to validate whether the present strategy for target prediction is biased by the 4 modeling per se. Moreover, we generated a new 1024-region parcellation template to 5 examine whether the prediction of targets or strengths was biased by a specific brain 6 parcellation scheme. As for the results of individual patients, we assessed the 7 statistical significance (one sample t-test) and the effect size (Cohen's d value) of the 8 simulated therapeutic effects for all brain regions. We assigned the rank for each brain 9 region across individuals and summarized the occurring times of the ranks. The 10 optimal neurostimulation strength of each region for each individual patient was also 11 plotted and summarized statistically (one sample t-test). For external validation, we 12 repeated the same procedure using an independent public dataset (PPMI PD patients). 13
To reveal the extent of rectification of network topology achieved through 14 neurostimulation, we conducted edge-wise statistical comparison between the two 15 groups. The results of two sample t-tests after Bonferroni correction for multiple 16 comparisons (p < 0.05 corrected) were categorized into three types: removed 17 abnormal connections (i.e., significantly different between the PD and HC groups 18 before, but not after neurostimulation); newly emerged abnormal connections, and 19 unchanged abnormal connections. Finally, to examine the relationship between the 20 predicted priority of brain regions and symptom severity, a Kendall rank correlation 1 was calculated between each target's rank and UPDRS-III score for two datasets. Supplementary Information accompanies this paper available at online. 
